Carol Moreno Quinn

机构：Vifor Pharma (Switzerland) · ORCID：0000-0003-2741-3991

发表论文 36 篇 · 总被引 265 次 · h-index 8

代表论文

Patiromer for the management of hyperkalaemia in patients receiving renin–angiotensin–aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial (2021 · European Journal of Heart Failure · 被引 45)
Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine (2024 · Kidney International · 被引 37)
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland (2022 · PharmacoEconomics - Open · 被引 32)
Characteristics, Symptom Severity, and Experiences of Patients Reporting Chronic Kidney Disease in the PatientsLikeMe Online Health Community: Retrospective and Qualitative Study (2020 · Journal of Medical Internet Research · 被引 27)
Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials (2020 · Nephrology Dialysis Transplantation · 被引 26)
Patiromer Treatment in Patients With CKD, Hyperkalemia, and Hyperphosphatemia: A Post Hoc Analysis of 3 Clinical Trials (2023 · American Journal of Kidney Diseases · 被引 14)